MIP: Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Dr Mohit Saxena
M3 India Newsdesk Dec 14, 2023
MIP: Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Dr Mohit Saxena
Watch Dr Mohit Saxena discuss an overview ... more»Watch Dr Mohit Saxena discuss an overview of immunotherapy's role in treating renal cell carcinoma, covering its mechanisms, and rationale for combination therapies. He also explains adjuvant and metastatic treatment applications and potential immune-related adverse events. «less
By Mohit Saxena | Dec 14, 2023
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
